HIV-RNA PCR - Qualitative, in Pimpri Chinchwad

HIV RNA PCR qualitative test detects HIV genetic material (viral RNA) in blood using polymerase chain reaction to determine whether infection is is present. It’s used for early (acute) diagnosis, in newborns of HIV-positive mothers, or when antibody tests are inconclusive. Results are reported as detected/not detected (qualitative), giving higher early sensitivity than antibody tests but not a viral load.

Qualitative HIV PCR detects whether HIV genetic material is present (yes/no), used for early diagnosis—especially in newborns—and initial screening. Quantitative HIV PCR measures how much virus is present (viral load, e.g., copies/mL) and is used to monitor disease progression and antiretroviral treatment response. Qualitative answers presence; quantitative guides therapy decisions and tracks trends over time.

HIV RNA PCR (viral load) is reported as copies per milliliter. "Undetectable" or values like "<50 copies/mL" mean virus is below the test’s detection limit—usually indicating effective antiretroviral therapy and very low transmission risk. Detectable or rising copies indicate ongoing replication, possible treatment failure, or acute infection. Compare serial results, note the test’s sensitivity, and discuss changes with your clinician for interpretation and management.

A qualitative HIV test determines whether HIV infection markers (antibodies and/or antigen such as p24) are present or absent in a sample, producing a reactive (positive) or non-reactive (negative) result. It does not measure virus quantity. Tests include rapid antibody/antigen immunoassays and laboratory serologic assays. Reactive results require confirmatory testing and clinical follow-up according to testing guidelines.

PCR detects HIV genetic material (RNA or proviral DNA) and can identify infection very early or in infants. A positive PCR strongly indicates infection, but adults typically receive diagnosis through combined antigen/antibody testing with confirmatory assays; repeat PCR or supplemental tests are used to rule out rare false positives or contamination. Clinical correlation and follow-up testing are recommended.

No. An HIV RNA PCR (nucleic acid) test is unlikely to detect infection just three days after exposure. Most RNA tests reliably detect HIV RNA beginning about 7–10 days after exposure, often around 10–14 days; some require longer. If you had a high‑risk exposure, seek medical advice and repeat testing per recommended intervals (around 10–14 days, 4–6 weeks, and at 3 months).